Recent Updates
Recently added Catalysts
SMMT

Summit Therapeutics plc : Block listing Interim Review

Key Takeaway: Accessibility: Skip TopNav Summit Therapeutics plc : Block listing Interim Review April 06, 2018 09:15 ET Summit Therapeutics plc Summit Therapeutics plc BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Name of

Full Press Release Details

Accessibility: Skip TopNav

Summit Therapeutics plc : Block listing Interim Review

April 06, 2018 09:15 ET
Summit Therapeutics plc
Summit Therapeutics plc
BLOCK LISTING SIX MONTHLY RETURN
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Name of applicant : Summit Therapeutics plc
Name of scheme: 2005 EMI Scheme
Period of return: From: 23 Oct 2017 To: 05 Apr 2018
Balance of unallotted securities under scheme(s) from previous return: 4,454,158
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Zero
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 2,884
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 4,451,274
Name of applicant : Summit Therapeutics plc
Name of scheme: 2016 Long term Incentive Plan
Period of return: From: 23 Oct 2017 To: 05 Apr 2018
Balance of unallotted securities under scheme(s) from previous return: 3,535,549
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 701,496
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 1,332
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 4,235,713
Name of contact: Richard Pye
Telephone number of contact: +44 (0)1235 443951
Last updated: Apr 6, 2018